Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

High testosterone increases heart disease risk in women with PCOS.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Various potential triggers may be causing the rise in frontal fibrosing alopecia, and avoiding these could help stop the disease's increase.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Elderly abuse is often by family members, and doctors, especially dermatologists, can spot it by looking for unusual injuries and malnutrition.

Smoking doesn't cause or prevent Frontal Fibrosing Alopecia, hormonal imbalance may be involved, and a combination of antiandrogens and steroids can help stabilize the condition.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Removing an adrenal tumor can significantly reduce high androgen levels in postmenopausal women.

FFA's causes may include environmental triggers and genetic factors.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Age, smoking, and lower BMI increase facial wrinkles; men wrinkle more than women, except in old age; pale skin and certain hormonal factors can protect against wrinkles.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.